Roger M. Perlmutter
Chief Executive Officer and Director · Eikon Therapeutics, Inc.
Individual
- 2026
- Mar 4, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Roger M. Perlmutter files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Column Group IV GP, LP - $39.15M in EIKN purchases and sales in the last 12 months
- Josh Wolfe - $5.00M in EIKN purchases and sales in the last 12 months
- Lux Venture Partners V, LLC - $5.00M in EIKN purchases and sales in the last 12 months
- Kenneth C. Frazier - $2.00M in EIKN purchases and sales in the last 12 months
- Foresite Capital Management IV, LLC - $1000K in EIKN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Roger M. Perlmutter?
Roger M. Perlmutter is a corporate insider, tracked as Chief Executive Officer and Director of Eikon Therapeutics, Inc. (EIKN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Roger M. Perlmutter last file a Form 4?
The most recent primary Form 4 on record is dated 4 March 2026, one of 2 filings going back to 2026.
